Clinical trial
Effect of Enhanced External Counterpulsation on the Rehabilitation of Patients With Acute Myocardial Infarction After Drug-Coated Balloon-Based Percutaneous Coronary Intervention
NCT06877390 is registered in ClinicalTrials.gov with Chongming Hospital Affiliated to Shanghai University of Health & Medicine Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Enhanced External Counterpulsation on the Rehabilitation of Patients With Acute Myocardial Infarction After Drug-Coated Balloon-Based Percutaneous Coronary Intervention
- Lead sponsor
- Chongming Hospital Affiliated to Shanghai University of Health & Medicine Sciences
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 1, 2023
- Completion date
- April 30, 2024
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute myocardial infarction (ami), cardiac rehabilitation, drug-coated balloon, enhanced external counterpulsation (eecp)